Patents by Inventor Lowell Brady

Lowell Brady has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29
    Publication number: 20070172923
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 17, 2006
    Publication date: July 26, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski
  • Homogeneous preparations of IL-28 and IL-29
    Publication number: 20070166282
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 13, 2006
    Publication date: July 19, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski
  • Homogeneous preparations of IL-28 and IL-29
    Publication number: 20070154446
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 13, 2006
    Publication date: July 5, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski
  • HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29
    Publication number: 20070117967
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 19, 2006
    Publication date: May 24, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski
  • HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29
    Publication number: 20070073044
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 19, 2006
    Publication date: March 29, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski
  • Homogeneous preparations of IL-28 and IL-29
    Publication number: 20070065406
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 13, 2006
    Publication date: March 22, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Boukowski
  • HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29
    Publication number: 20070066810
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 19, 2006
    Publication date: March 22, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski
  • HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29
    Publication number: 20070059313
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 19, 2006
    Publication date: March 15, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski
  • HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29
    Publication number: 20070059804
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 18, 2006
    Publication date: March 15, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski
  • HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29
    Publication number: 20070054375
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 17, 2006
    Publication date: March 8, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski
  • HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29
    Publication number: 20070055053
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 19, 2006
    Publication date: March 8, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski
  • HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29
    Publication number: 20070053875
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 17, 2006
    Publication date: March 8, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski
  • HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29
    Publication number: 20070055052
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 19, 2006
    Publication date: March 8, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski
  • HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29
    Publication number: 20070054376
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 18, 2006
    Publication date: March 8, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski
  • HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29
    Publication number: 20070054377
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 19, 2006
    Publication date: March 8, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski
  • HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29
    Publication number: 20070055051
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 16, 2006
    Publication date: March 8, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski
  • HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29
    Publication number: 20070054374
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 17, 2006
    Publication date: March 8, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski
  • HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29
    Publication number: 20070055054
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 19, 2006
    Publication date: March 8, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski
  • HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29
    Publication number: 20070048844
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 17, 2006
    Publication date: March 1, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski
  • HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29
    Publication number: 20070048275
    Abstract: Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
    Type: Application
    Filed: October 16, 2006
    Publication date: March 1, 2007
    Inventors: Lowell Brady, Kevin Klucher, Chung Chan, Dennis Dong, Hong Liu, Paul Sheppard, Thomas Bukowski